Data is not available at this time.
Delta Plus Group operates in the personal protective equipment (PPE) industry, specializing in the design, manufacture, and global distribution of safety gear. The company’s diversified product portfolio includes head, hand, body, foot, and fall protection solutions, catering to industrial, construction, and DIY markets. Its revenue model is driven by B2B sales, leveraging long-term contracts with industrial clients and distributors, while also serving retail demand through specialized safety wear. Delta Plus has established a strong presence in Europe, with expanding footprints in emerging markets, positioning itself as a mid-tier player with a reputation for reliability and compliance with stringent safety standards. The company’s competitive edge lies in its vertically integrated manufacturing capabilities, allowing for cost control and customization, while its R&D focus ensures adherence to evolving regulatory requirements. Despite fragmentation in the PPE sector, Delta Plus maintains a defensible niche through brand recognition and a balanced mix of proprietary and third-party distribution channels.
Delta Plus reported revenue of €400.1 million for the latest fiscal period, with net income of €31.1 million, reflecting a net margin of approximately 7.8%. The absence of disclosed operating cash flow and capital expenditures limits deeper efficiency analysis, but the company’s profitability suggests disciplined cost management. Its diluted EPS of €4.23 indicates reasonable earnings distribution across its 7.36 million outstanding shares.
The company’s earnings power is underscored by its steady net income, though the lack of operating cash flow data restricts a full assessment of cash conversion efficiency. With a market cap of €373.9 million, Delta Plus trades at a P/E multiple of around 12x, aligning with mid-cap industrials. Its capital structure appears moderately leveraged, with debt used to support growth initiatives.
Delta Plus holds €37.8 million in cash and equivalents against total debt of €194.8 million, indicating a leveraged but manageable position. The debt-to-equity ratio cannot be calculated without shareholder equity data, but the company’s ability to sustain profitability suggests adequate liquidity. Its dividend payout of €1.25 per share reflects a commitment to shareholder returns without straining financial flexibility.
Revenue growth trends are not explicitly detailed, but the company’s global distribution network and PPE demand tailwinds suggest stable expansion potential. The dividend yield, based on current share price, appears sustainable, balancing reinvestment needs with investor returns. Delta Plus’s focus on regulatory-compliant products aligns with long-term industry growth drivers.
The market values Delta Plus at a beta of 0.964, indicating lower volatility relative to the broader market. Its valuation multiples reflect expectations of steady, albeit unspectacular, growth in the defensive PPE sector. Investors likely prize the company’s resilient end-market exposure and consistent profitability.
Delta Plus benefits from its integrated supply chain and regulatory expertise, critical in the compliance-driven PPE market. The company is well-positioned to capitalize on workplace safety trends, though competition and input cost pressures remain risks. Strategic acquisitions or geographic expansion could further solidify its market position.
Company description, financials, and market data sourced from publicly available disclosures and Euronext Paris exchange filings.
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |